Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.atherosclerosis.2015.12.032
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for:
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Subjectcholesterol; cholesterol/absorption; cholesterol/cell and tissue; drug therapy/hypolipidemic drugs; genetics; proteomics
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
IdentifierS0021915015302616
NPARC number21277181
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier23d17299-47db-47c2-8391-f5a1b9ba5426
Record created2016-01-05
Record modified2020-04-22
Date modified: